JP2021102633A5 - - Google Patents

Download PDF

Info

Publication number
JP2021102633A5
JP2021102633A5 JP2021047470A JP2021047470A JP2021102633A5 JP 2021102633 A5 JP2021102633 A5 JP 2021102633A5 JP 2021047470 A JP2021047470 A JP 2021047470A JP 2021047470 A JP2021047470 A JP 2021047470A JP 2021102633 A5 JP2021102633 A5 JP 2021102633A5
Authority
JP
Japan
Prior art keywords
binding protein
fragment
seq
chain variable
variable domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021047470A
Other languages
English (en)
Japanese (ja)
Other versions
JP7140867B2 (ja
JP2021102633A (ja
Filing date
Publication date
Priority claimed from JP2018559164A external-priority patent/JP6883590B2/ja
Application filed filed Critical
Publication of JP2021102633A publication Critical patent/JP2021102633A/ja
Publication of JP2021102633A5 publication Critical patent/JP2021102633A5/ja
Priority to JP2022067548A priority Critical patent/JP2022095910A/ja
Application granted granted Critical
Publication of JP7140867B2 publication Critical patent/JP7140867B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021047470A 2016-01-29 2021-03-22 Pd-l1に結合する抗原結合性タンパク質 Active JP7140867B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022067548A JP2022095910A (ja) 2016-01-29 2022-04-15 Pd-l1に結合する抗原結合性タンパク質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662288912P 2016-01-29 2016-01-29
US62/288,912 2016-01-29
JP2018559164A JP6883590B2 (ja) 2016-01-29 2017-01-27 Pd−l1に結合する抗原結合性タンパク質

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018559164A Division JP6883590B2 (ja) 2016-01-29 2017-01-27 Pd−l1に結合する抗原結合性タンパク質

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022067548A Division JP2022095910A (ja) 2016-01-29 2022-04-15 Pd-l1に結合する抗原結合性タンパク質

Publications (3)

Publication Number Publication Date
JP2021102633A JP2021102633A (ja) 2021-07-15
JP2021102633A5 true JP2021102633A5 (https=) 2021-11-11
JP7140867B2 JP7140867B2 (ja) 2022-09-21

Family

ID=59386438

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018559164A Active JP6883590B2 (ja) 2016-01-29 2017-01-27 Pd−l1に結合する抗原結合性タンパク質
JP2021047470A Active JP7140867B2 (ja) 2016-01-29 2021-03-22 Pd-l1に結合する抗原結合性タンパク質
JP2022067548A Pending JP2022095910A (ja) 2016-01-29 2022-04-15 Pd-l1に結合する抗原結合性タンパク質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2018559164A Active JP6883590B2 (ja) 2016-01-29 2017-01-27 Pd−l1に結合する抗原結合性タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022067548A Pending JP2022095910A (ja) 2016-01-29 2022-04-15 Pd-l1に結合する抗原結合性タンパク質

Country Status (17)

Country Link
US (4) US10118963B2 (https=)
EP (1) EP3408400B1 (https=)
JP (3) JP6883590B2 (https=)
KR (2) KR102927822B1 (https=)
CN (2) CN109715821B (https=)
AU (1) AU2017212717B2 (https=)
BR (1) BR112018015480A2 (https=)
CA (1) CA3013051A1 (https=)
CL (1) CL2018002034A1 (https=)
EA (1) EA037855B1 (https=)
ES (1) ES2986360T3 (https=)
IL (1) IL260846B2 (https=)
MX (2) MX2018009228A (https=)
PH (1) PH12018501611A1 (https=)
SG (1) SG11201806496SA (https=)
TW (1) TWI760323B (https=)
WO (1) WO2017132562A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220084444A (ko) 2012-05-31 2022-06-21 소렌토 쎄라퓨틱스, 인코포레이티드 Pd-l1에 결합하는 항원 결합 단백질
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
WO2017132562A1 (en) * 2016-01-29 2017-08-03 Heyue Zhou Antigen binding proteins that bind pd-l1
US9567399B1 (en) 2016-06-20 2017-02-14 Kymab Limited Antibodies and immunocytokines
RU2769282C2 (ru) 2016-06-20 2022-03-30 Кимаб Лимитед Анти-PD-L1 и IL-2 цитокины
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
MX2020009550A (es) * 2018-03-22 2020-11-11 Keires Ag Proteinas de union a antigeno antagonistas.
MX2020010653A (es) 2018-04-09 2020-10-28 Origincell Therapeutics Co Ltd Anticuerpo anti-muerte programada-ligando 1 y su uso.
EP3818085A4 (en) * 2018-06-01 2022-03-09 Tayu Huaxia Biotech Medical Group Co., Ltd. COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISEASES OR DISORDERS
WO2019227490A1 (en) 2018-06-01 2019-12-05 Tayu Huaxia Biotech Medical Group Co., Ltd. Compositions and methods for imaging
MX2021002077A (es) * 2018-08-20 2021-05-27 1Globe Biomedical Co Ltd Nuevas composiciones de anticuerpos para la inmunoterapia contra el cáncer.
US20220177561A1 (en) * 2018-12-11 2022-06-09 Sanford Burnham Prebys Medical Discovery Institute Models and Methods Useful for the Treatment of Serrated Colorectal Cancer
CN113795511B (zh) 2019-01-23 2024-07-23 大有华夏生物医药集团有限公司 抗pd-l1双抗体及其用途
JP7725066B2 (ja) * 2019-04-18 2025-08-19 キューエルエスエフ バイオセラピューティック インコーポレイテッド ヒト化抗pd-l1抗体
KR20220012856A (ko) * 2019-08-29 2022-02-04 레메젠 코, 리미티드 항 pd―l1 항체 및 그의 용도
JP2023532279A (ja) * 2020-06-26 2023-07-27 ソレント・セラピューティクス・インコーポレイテッド 免疫調節性融合タンパク質を発現する腫瘍溶解性単純ヘルペスウイルス(hsv)
EP4208204A1 (en) 2020-09-02 2023-07-12 Mayo Foundation for Medical Education and Research Antibody-nanoparticle complexes and methods for making and using the same
TWI907564B (zh) 2020-11-16 2025-12-11 南韓商益免安協公司 用於預測對免疫抗癌劑的治療反應的生物標誌物及其用途
CA3219221A1 (en) * 2021-05-07 2022-11-10 Immuneoncia Therapeutics, Inc. Bispecific antibody specifically binding to cd47 and pd-l1
WO2022261262A1 (en) 2021-06-09 2022-12-15 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
US20260083777A1 (en) * 2022-09-19 2026-03-26 Sonoma Biotherapeutics, Inc. Citrullinated antigen-specific chimeric antigen receptors for targeting regulatory t cells to treat hidradenitis suppurativa
CN120813375A (zh) 2023-01-30 2025-10-17 凯玛布有限公司 抗体
WO2025183487A1 (en) * 2024-02-29 2025-09-04 Yuhan Corporation Anti-tigit/anti-pd-l1 bispecific antibody and use thereof
CN121175334A (zh) 2024-04-13 2025-12-19 益免安协公司 在治疗癌症中的使用pd-l1抑制剂的新辅助免疫疗法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3817827A (en) 1972-03-30 1974-06-18 Scott Paper Co Soft absorbent fibrous webs containing elastomeric bonding material and formed by creping and embossing
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4002531A (en) 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6010902A (en) 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
JP3051145B2 (ja) 1990-08-28 2000-06-12 住友製薬株式会社 新規なポリエチレングリコール誘導体修飾ペプチド
US5582996A (en) 1990-12-04 1996-12-10 The Wistar Institute Of Anatomy & Biology Bifunctional antibodies and method of preparing same
DE4118120A1 (de) 1991-06-03 1992-12-10 Behringwerke Ag Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US5281698A (en) 1991-07-23 1994-01-25 Cetus Oncology Corporation Preparation of an activated polymer ester for protein conjugation
US7018809B1 (en) 1991-09-19 2006-03-28 Genentech, Inc. Expression of functional antibody fragments
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
JPH07509128A (ja) 1992-07-13 1995-10-12 バイオネブラスカ・インコーポレーテッド 組換型ポリペプチドの修飾方法
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
PT672141E (pt) 1992-10-23 2003-09-30 Immunex Corp Metodos de preparacao de proteinas oligomericas soluveis
US5446090A (en) 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
EP1105427A2 (en) 1998-08-17 2001-06-13 Abgenix, Inc. Generation of modified molecules with increased serum half-lives
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
US6938003B2 (en) 2000-06-30 2005-08-30 Mahesh Harpale Method and apparatus for a credibility reporting system to augment an online exchange
EP2295450B1 (en) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegylated interleukin-10
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
US7902338B2 (en) * 2003-07-31 2011-03-08 Immunomedics, Inc. Anti-CD19 antibodies
HRP20140102T1 (hr) 2007-06-01 2014-03-28 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Cjepivo za prevenciju relapsa raka dojke
US8877688B2 (en) * 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
KR20220084444A (ko) * 2012-05-31 2022-06-21 소렌토 쎄라퓨틱스, 인코포레이티드 Pd-l1에 결합하는 항원 결합 단백질
BR112015007672A2 (pt) * 2012-10-04 2017-08-08 Dana Farber Cancer Inst Inc anticorpos anti-pd-l1 monoclonais humanos e métodos de uso
AR093984A1 (es) * 2012-12-21 2015-07-01 Merck Sharp & Dohme Anticuerpos que se unen a ligando 1 de muerte programada (pd-l1) humano
WO2014194302A2 (en) * 2013-05-31 2014-12-04 Sorrento Therapeutics, Inc. Antigen binding proteins that bind pd-1
CA2944767C (en) 2014-04-04 2022-07-12 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
CN105238762A (zh) * 2015-10-26 2016-01-13 无锡傲锐东源生物科技有限公司 抗pd-1蛋白单克隆抗体杂交瘤细胞及其产生的抗pd-1单克隆抗体和应用
WO2017132562A1 (en) * 2016-01-29 2017-08-03 Heyue Zhou Antigen binding proteins that bind pd-l1

Similar Documents

Publication Publication Date Title
JP2021102633A5 (https=)
JP2022058932A5 (https=)
JP2016521692A5 (https=)
TWI659969B (zh) 一種抗pd-1的單株抗體及其獲得方法
JP2018510151A5 (https=)
TWI821474B (zh) Cd3抗體及其藥物用途
JP2018504105A5 (https=)
JP2021502104A5 (https=)
JP2019507183A5 (https=)
JP2015519375A5 (https=)
JP2021525546A5 (https=)
JP2019214586A5 (https=)
CN112969476B (zh) 多特异性蛋白分子
JP2020525032A5 (https=)
JP2020500523A5 (https=)
JP2020510422A5 (https=)
HRP20220131T1 (hr) Nova terapija s t-staničnim receptorima i imunološka terapija koja koristi iste
JP2018532766A5 (https=)
JP2012501669A5 (https=)
JP2019507135A5 (https=)
JP2013506428A5 (https=)
RU2017121326A (ru) Общие легкие цепи и способы их применения
RU2009128064A (ru) Антитела к cd44
JP2011526785A5 (https=)
CN116648462A (zh) Cd3人源化抗体及其应用